...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: IR response

The problem I see with Open-Label Study, ...why would patients admitted to the hospital with COVID partake in the study if they are not given apabetalone? What benefit do they get out of the study except being a good samaritan??? Thoughts?

 

Koo

 

Share
New Message
Please login to post a reply